1. Home
  2. ATRA vs SRL Comparison

ATRA vs SRL Comparison

Compare ATRA & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • SRL
  • Stock Information
  • Founded
  • ATRA 2012
  • SRL 2017
  • Country
  • ATRA United States
  • SRL China
  • Employees
  • ATRA N/A
  • SRL N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • SRL Professional Services
  • Sector
  • ATRA Health Care
  • SRL Consumer Discretionary
  • Exchange
  • ATRA Nasdaq
  • SRL Nasdaq
  • Market Cap
  • ATRA 67.9M
  • SRL 79.0M
  • IPO Year
  • ATRA 2014
  • SRL N/A
  • Fundamental
  • Price
  • ATRA $12.18
  • SRL $5.25
  • Analyst Decision
  • ATRA Strong Buy
  • SRL
  • Analyst Count
  • ATRA 3
  • SRL 0
  • Target Price
  • ATRA $21.00
  • SRL N/A
  • AVG Volume (30 Days)
  • ATRA 59.4K
  • SRL 3.1K
  • Earning Date
  • ATRA 08-11-2025
  • SRL 04-30-2025
  • Dividend Yield
  • ATRA N/A
  • SRL 19.28%
  • EPS Growth
  • ATRA N/A
  • SRL N/A
  • EPS
  • ATRA 0.56
  • SRL N/A
  • Revenue
  • ATRA $188,667,000.00
  • SRL $24,535,042.00
  • Revenue This Year
  • ATRA N/A
  • SRL N/A
  • Revenue Next Year
  • ATRA N/A
  • SRL N/A
  • P/E Ratio
  • ATRA $21.89
  • SRL N/A
  • Revenue Growth
  • ATRA 202.41
  • SRL N/A
  • 52 Week Low
  • ATRA $5.01
  • SRL $5.13
  • 52 Week High
  • ATRA $18.71
  • SRL $9.99
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 53.50
  • SRL 42.08
  • Support Level
  • ATRA $11.70
  • SRL $5.16
  • Resistance Level
  • ATRA $13.20
  • SRL $5.47
  • Average True Range (ATR)
  • ATRA 0.73
  • SRL 0.20
  • MACD
  • ATRA -0.03
  • SRL 0.02
  • Stochastic Oscillator
  • ATRA 47.96
  • SRL 15.58

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: